Fujisawa M, Onodera T, Kuroda D, Kewcharoenwong C, Sasaki M, Itakura Y
NPJ Vaccines. 2025; 10(1):39.
PMID: 39988605
PMC: 11847937.
DOI: 10.1038/s41541-025-01073-5.
Lau C, Oh H, Aw T
Vaccines (Basel). 2025; 13(1).
PMID: 39852788
PMC: 11768752.
DOI: 10.3390/vaccines13010009.
Jiang W, Wu J, He J, Xia A, Wu W, Gao Y
Vaccines (Basel). 2024; 12(11).
PMID: 39591107
PMC: 11598389.
DOI: 10.3390/vaccines12111204.
Yisimayi A, Song W, Jian F, Yu Y, Chen X, Xu Y
Emerg Microbes Infect. 2024; 13(1):2412623.
PMID: 39360822
PMC: 11486138.
DOI: 10.1080/22221751.2024.2412623.
Suwarti S, Lazarus G, Zanjabila S, Sinto R, Fransiska F, Deborah T
BMC Infect Dis. 2024; 24(1):768.
PMID: 39090537
PMC: 11292869.
DOI: 10.1186/s12879-024-09644-y.
Impact of COVID-19 Vaccination on Mortality and Clinical Outcomes in Hemodialysis Patients.
Hu R, Yin J, He T, Zhu Y, Li Y, Gao J
Vaccines (Basel). 2024; 12(7).
PMID: 39066437
PMC: 11281375.
DOI: 10.3390/vaccines12070799.
SARS-CoV-2 Neutralization Assays Used in Clinical Trials: A Narrative Review.
Sun Y, Huang W, Xiang H, Nie J
Vaccines (Basel). 2024; 12(5).
PMID: 38793805
PMC: 11125816.
DOI: 10.3390/vaccines12050554.
Immunogenicity and Safety of Half-Dose Heterologous mRNA-1273 Booster Vaccination for Adults Primed with the CoronaVac and ChAdOx1-S Vaccines for SARS-CoV-2.
Putri N, Zhafira A, Wicaksana P, Sinto R, Hanafi G, Wiyono L
Vaccines (Basel). 2024; 12(4).
PMID: 38675727
PMC: 11053985.
DOI: 10.3390/vaccines12040344.
The Effect of Vaccination with Pfizer-BioNTech or CoronaVac on Disease Prognosis Among Hospitalized COVID-19 Patients.
Guldan M, Ates S, Sarioglu S, Suyabatmaz S, Irkoren P, Tekin S
Infect Dis Clin Microbiol. 2024; 5(2):106-112.
PMID: 38633010
PMC: 10985826.
DOI: 10.36519/idcm.2023.226.
Immunogenicity and efficacy of VLA2001 vaccine against SARS-CoV-2 infection in male cynomolgus macaques.
Galhaut M, Lundberg U, Marlin R, Schlegl R, Seidel S, Bartuschka U
Commun Med (Lond). 2024; 4(1):62.
PMID: 38570605
PMC: 10991505.
DOI: 10.1038/s43856-024-00488-w.
Comprehensive evaluation of inactivated SARS-CoV-2 vaccination on sperm parameters and sex hormones.
Dong Y, Ba Z, Qin Y, Ma J, Li Y, Zhang Y
Front Immunol. 2024; 15:1321406.
PMID: 38469318
PMC: 10925671.
DOI: 10.3389/fimmu.2024.1321406.
Impact of Tuberculosis on Disease Severity and Viral Shedding Duration in COVID-19 Patients.
Huang W, Liu P, Yan B, Zheng F, Yang Y, Xi X
Viruses. 2024; 16(2).
PMID: 38400036
PMC: 10893069.
DOI: 10.3390/v16020260.
Immunological imprinting shapes the specificity of human antibody responses against SARS-CoV-2 variants.
Johnston T, Li S, Painter M, Atkinson R, Douek N, Reeg D
medRxiv. 2024; .
PMID: 38260304
PMC: 10802657.
DOI: 10.1101/2024.01.08.24301002.
Strategies for the development and approval of COVID-19 vaccines and therapeutics in the post-pandemic period.
Ao D, He X, Liu J, Xu L
Signal Transduct Target Ther. 2023; 8(1):466.
PMID: 38129394
PMC: 10739883.
DOI: 10.1038/s41392-023-01724-w.
Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting.
Yisimayi A, Song W, Jian F, Yu Y, Chen X, Xu Y
Nature. 2023; 625(7993):148-156.
PMID: 37993710
PMC: 10764275.
DOI: 10.1038/s41586-023-06753-7.
SARS-CoV-2 and innate immunity: the good, the bad, and the "goldilocks".
Sievers B, Cheng M, Csiba K, Meng B, Gupta R
Cell Mol Immunol. 2023; 21(2):171-183.
PMID: 37985854
PMC: 10805730.
DOI: 10.1038/s41423-023-01104-y.
Comparison of Antibody Responses After CoronaVac and BNT162b2 Vaccines in Healthcare Workers.
Oktay Gultekin E, Gultekin O
Indian J Microbiol. 2023; 63(3):361-368.
PMID: 37781011
PMC: 10533450.
DOI: 10.1007/s12088-023-01098-1.
Targeting materials and strategies for RNA delivery.
Lin L, Su K, Cheng Q, Liu S
Theranostics. 2023; 13(13):4667-4693.
PMID: 37649616
PMC: 10465230.
DOI: 10.7150/thno.87316.
Antibiotic Use Prior to COVID-19 Vaccine Is Associated with Higher Risk of COVID-19 and Adverse Outcomes: A Propensity-Scored Matched Territory-Wide Cohort.
Cheung K, Yan V, Lam L, Ye X, Hung I, Chan E
Vaccines (Basel). 2023; 11(8).
PMID: 37631909
PMC: 10459914.
DOI: 10.3390/vaccines11081341.
Immunogenicity of Mix-and-Match CoronaVac/BNT162b2 Regimen versus Homologous CoronaVac/CoronaVac Vaccination: A Single-Blinded, Randomized, Parallel Group Superiority Trial.
Samoud S, Bettaieb J, Gdoura M, Kharroubi G, Ben Ghachem F, Zamali I
Vaccines (Basel). 2023; 11(8).
PMID: 37631897
PMC: 10459159.
DOI: 10.3390/vaccines11081329.
